Pages that link to "Q35977908"

The following pages link to Chemotherapy of advanced breast cancer: outcome and prognostic factors (Q35977908):

Displaying 37 items.

• Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer (Q32137228) (← links)
• Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer (Q33264871) (← links)
• Mitomycin C and Vinorelbine in Pretreated Breast Cancer (Q33501356) (← links)
• Key issues in the treatment of advanced breast cancer. Expectations and outcomes (Q33573907) (← links)
• Role of decision analysis in relation to clinical trials and a US perspective of the Battelle model (Q33573917) (← links)
• Effects of adjuvant chemotherapy on the natural history and likelihood of therapeutic efficacy in advanced breast cancer patients: a critical literature review (Q33585752) (← links)
• Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer (Q33961200) (← links)
• Surgical management of breast cancer liver metastases (Q34846333) (← links)
• Continuous 5-fluorouracil in the treatment of breast cancer (Q36079497) (← links)
• Potential for cost economies in guiding therapy in patients with metastatic breast cancer (Q36081871) (← links)
• Do patients with advanced breast cancer benefit from chemotherapy? (Q36115775) (← links)
• Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease (Q36116173) (← links)
• A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer (Q36134486) (← links)
• High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group. (Q36136361) (← links)
• Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer (Q36136402) (← links)
• A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer (Q36292746) (← links)
• Inequalities in breast cancer care and outcome (Q36431035) (← links)
• Chemotherapy for advanced breast cancer: what influences oncologists' decision-making? (Q36623000) (← links)
• New treatments for advanced cancer: an approach to prioritization (Q36691987) (← links)
• Radiofrequency Ablation in the Treatment of Breast Cancer Liver Metastases (Q37786734) (← links)
• Clinical Trial: Hematopoietic Progenitor Cell Transplantation in Breast Cancer: Current Status and Future Directions (Q40865994) (← links)
• The case for high-dose adjuvant chemotherapy in breast cancer: (II) clinical experience (Q41326861) (← links)
• Predictive factors for response to cytotoxic treatment in advanced breast cancer: a review (Q41463944) (← links)
• The role of docetaxel in improving treatment outcomes in advanced breast cancer (Q41714189) (← links)
• Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients (Q45870042) (← links)
• Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer (Q46988786) (← links)
• Cost effectiveness of letrozole in the treatment of advanced breast cancer in postmenopausal women in the UK. (Q50655532) (← links)
• Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost (Q52207128) (← links)
• 5FU Continuous Infusion in Heavily Pretreated Advanced Breast Cancer Patients (Q52891237) (← links)
• CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. (Q53408071) (← links)
• An economic evaluation of the optimal workload in treating surgical patients in a breast unit (Q57551625) (← links)
• The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone (Q59289190) (← links)
• Uncertain benefit from surgery in patients with lung metastases from breast carcinoma (Q62785649) (← links)
• Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer (Q73231229) (← links)
• Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients (Q73744768) (← links)
• Weekly schedule of vinorelbine in pretreated breast cancer patients (Q73836620) (← links)
• [Therapy response of liver tumors after selective internal radiation therapy] (Q81920607) (← links)